Low- versus high-dose trimethoprim-sulfamethoxazole for the treatment of <i>Stenotrophomonas maltophilia</i> pneumonia

20252 citationsJournal Articlegold Open Access

Authors

Lynn Wardlow · The Ohio State University Wexner Medical Center

Kelci Coe · The Ohio State University Wexner Medical Center

José A. Bazan · The Ohio State University Wexner Medical Center

Joel R. Leininger · The Ohio State University Wexner Medical Center

Abstract

No differences in clinical success or adverse events were observed in patients with <i>S. maltophilia</i> pneumonia treated with either LD or HD TMP-SMX.

Topics & Keywords

Infections and bacterial resistance Nosocomial Infections in ICU

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Antimicrobial Stewardship & Healthcare Epidemiology

Volume 5, Issue 1, pp. e95-e95

DOI: 10.1017/ash.2025.64

Field-Weighted Citation Impact: 3.75